Dr. Joel A Kaplan is a Highland Park, Illinois based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Dr. Joel A Kaplan is 036.037013 for Ophthalmology in Illinois. Dr. Joel A Kaplan is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. Joel A Kaplan speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
M.D.
Gender:
Male
Practice Address:
1780 Ridge Rd, Highland Park, Illinois, 60035-2117
Phone:
847-831-2593
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1164702544
NPI Enumeration Date:
17 Aug, 2011
NPI Last Update On:
17 Aug, 2011
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Joel A Kaplan are as mentioned below.
License Number
Specialization
State
Status
036.037013
Ophthalmology
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1780 Ridge Rd, Highland Park, Illinois
Zip:
60035-2117
Phone Number:
847-831-2593
Fax Number:
--
Patients can reach Dr. Joel A Kaplan at 1780 Ridge Rd, Highland Park, Illinois or can call to book an appointment on 847-831-2593. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.